Early Treatment with Hydroxychloroquine and Azithromycin: A Real-Life Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients
Million, M.; Cortaredona, S.; Delorme, L.; Colson, P.; LEVASSEUR, A.; Tissot-Dupont, H.; bendamardji, K.; Lahouel, S.; LA SCOLA, B.; Camoin, L.; Fenollar, F.; Gautret, P.; Parola, P.; Lagier, J.-C.; Gentile, S.; BROUQUI, P.; Raoult, D.
Show abstract
The authors have withdrawn this manuscript because analytic strategies for this project have changed. Therefore, the authors do not wish this work to be cited as reference for the project.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study 96%
- Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients 94%
- Hydroxychloroquine For The Treatment Of Severe Respiratory Infection By COVID-19: A Randomized Controlled Trial 94%
Similar papers in this journal
- Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studies 96%
- A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19 95%
- Outcomes of Persons With COVID-19 in Hospitals With and Without Standard Treatment With (Hydroxy)chloroquine 94%
Similar papers in this journal
- Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials 93%
- Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials 93%
- Risk factors for severe outcomes of COVID-19: a rapid review 93%
Similar papers in this journal
- Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study 94%
- Janus Kinase-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis 94%
- Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study 92%
Similar papers in this journal
- A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration 93%
- Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19 93%
- Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.